Publications by authors named "Kay Greveson"

Claim this Profile
M
Management of Perianal Fistulas Associated with Crohn Disease: A Nurse's Perspective.
Kay Greveson, Ola Haj, Ailsa Hart, Parnia Geransar, Oded Zmora

Gastroenterol Nurs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to international travel in inflammatory bowel disease patients.
Kristina Aluzaite, Kay Greveson, Shomron Ben-Horin, Rupert Leong, Ola Haj

J Travel Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
HoUng Kim, Rieke Alten, Luisa Avedano, Axel Dignass, Fernando Gomollón, Kay Greveson

Drugs· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, Richard Appleby, Ian Arnott, Kay Greveson

Gut· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
HoUng Kim, Rieke Alten, Luisa Avedano, Axel Dignass, Fernando Gomollón, Kay Greveson

Drugs· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach.
Laurent Peyrin-Biroulet, Silvio Danese, Fraser Cummings, Raja Atreya, Kay Greveson

Expert Rev Gastroenterol Hepatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies.
Alessandro Armuzzi, Luisa Avedano, Kay Greveson, Taegyun Kang

J Crohns Colitis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas.
Webber Chan, Hang Hock Shim, Siew Chien Ng, , Jeffrey Liu, Kay Greveson

J Crohns Colitis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis.
Karen Kemp, Lesley Dibley, Usha Chauhan, Kay Greveson, Susanna Jäghult

J Crohns Colitis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review: advice lines for patients with inflammatory bowel disease.
Palle Bager, Usha Chauhan, Kay Greveson, Susanna Jäghult, Liesbeth Moortgat

Scand J Gastroenterol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Travel health and pretravel preparation in the patient with inflammatory bowel disease.
Kay Greveson, Thomas Shepherd, John P Mulligan, Mark Hamilton, Sue Woodward

Frontline Gastroenterol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of the inflammatory bowel disease nurse specialist.
Kay Greveson, Sue Woodward

Br J Nurs· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNFα therapy.
Kay Greveson, James Goodhand, Santino Capocci, Sue Woodward, Charles Murray

J Crohns Colitis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon γ-release assays for detecting latent tuberculosis infection in patients scheduled for anti-TNFα therapy.
Kay Greveson, Charlie Murray, Christos Toumpanakis, Owen Epstein, Mark Hamilton

Frontline Gastroenterol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can ELISpot replace the tuberculin skin test for latent tuberculosis?
Kay Greveson

Br J Nurs· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis